Mindfulness-based cognitive therapy neurobiology in treatment-resistant obsessive-compulsive disorder: A domain-related resting-state networks approach
- PMID: 38503084
- DOI: 10.1016/j.euroneuro.2024.02.011
Mindfulness-based cognitive therapy neurobiology in treatment-resistant obsessive-compulsive disorder: A domain-related resting-state networks approach
Abstract
Mindfulness-based cognitive therapy (MBCT) stands out as a promising augmentation psychological therapy for patients with obsessive-compulsive disorder (OCD). To identify potential predictive and response biomarkers, this study examines the relationship between clinical domains and resting-state network connectivity in OCD patients undergoing a 3-month MBCT programme. Twelve OCD patients underwent two resting-state functional magnetic resonance imaging sessions at baseline and after the MBCT programme. We assessed four clinical domains: positive affect, negative affect, anxiety sensitivity, and rumination. Independent component analysis characterised resting-state networks (RSNs), and multiple regression analyses evaluated brain-clinical associations. At baseline, distinct network connectivity patterns were found for each clinical domain: parietal-subcortical, lateral prefrontal, medial prefrontal, and frontal-occipital. Predictive and response biomarkers revealed significant brain-clinical associations within two main RSNs: the ventral default mode network (vDMN) and the frontostriatal network (FSN). Key brain nodes -the precuneus and the frontopolar cortex- were identified within these networks. MBCT may modulate vDMN and FSN connectivity in OCD patients, possibly reducing symptoms across clinical domains. Each clinical domain had a unique baseline brain connectivity pattern, suggesting potential symptom-based biomarkers. Using these RSNs as predictors could enable personalised treatments and the identification of patients who would benefit most from MBCT.
Keywords: Brain connectivity; Functional magnetic resonance imaging; Mindfulness-based interventions; Neurobiology; Neuroimaging; Obsessive-compulsive disorder.
Copyright © 2024 Elsevier B.V. and ECNP. All rights reserved.
Conflict of interest statement
Declaration of competing interest Over the past five years, Narcís Cardoner has received research grants and/or honorary fees as a consultant or speaker from various organizations, including Adamed, Angelini, Content Ed Net Communications, Elsevier, Esteve, Exeltis, Janssen, Lundbeck, Pfizer, Servier, Viatris, Fundació la Caixa, Carlos III Health Institute, ERA-NET Neuron, the Spanish Ministry of Science and Innovation (CIBERSAM), and Health Research and Innovation Strategic Plan (PERIS) 2016–2020, Marató TV3. Additionally, Pino Alonso has collaborated with Biohaven, Boston Scientific, Medtronic, and has received funding from Carlos III Health Institute and Marató TV3. All other authors declare that they have no conflicts of interest.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical